Peripheral neuropathy Board decisions

The Board granted a 30 percent rating for the veteran's residuals of left inguinal hernia repair with ilioinguinal neuropathy, which was previously service-connected.

The veteran's low back disability is currently rated at 20 percent, and a separate rating of 10 percent for peripheral neuropathy of the anterior left thigh is granted effective September 23, 2002.

The Board denied the veteran's claim for service connection for residuals of a cold injury to both feet, finding that there was no evidence of such an injury during his active military service and concluding that any current peripheral neuropathy is not related to his service.

The veteran's claims for an earlier effective date and CUE in a January 1999 rating decision are being remanded due to the need for VCAA compliance.

The veteran's claims for increased disability ratings for service-connected diabetes mellitus, peripheral neuropathy of the lower extremities, and diabetic retinopathy are being remanded due to procedural issues and the need for additional development.

The Board has received notification of the appellant's withdrawal of his appeal, and thus the case is dismissed.

The Board has determined that the veteran developed cerebral/cerebellar atrophy and peripheral neuropathy as a result of exposure to Agent Orange during service, granting service connection for these conditions.

The Board found that the veteran's sensorimotor polyneuropathy of the upper and lower extremities was not shown in service or within one year of separation, and there is no medical evidence of a nexus between any current condition and his service. The psychiatric disability claim was also denied as there were no current signs or symptoms on Axis I or Axis II.

The veteran's claims for service connection for diabetes mellitus, peripheral neuropathy of the left and right shoulder, dermatitis (claimed as a skin rash), and vision condition secondary to diabetes mellitus have all been denied. The Board found no evidence linking these conditions to service or Agent Orange exposure.

The veteran's service-connected disabilities do not render him unable to obtain or retain gainful employment.

The Board denied all the veteran's claims for increased ratings, finding that his conditions did not warrant a higher rating based on the evidence of record.

The veteran's claim for service connection for peripheral neuropathy and PTSD was denied. The Board found that the veteran did not have a current diagnosis of peripheral neuropathy related to his Vietnam service or Agent Orange exposure, and there were no verified in-service stressors for PTSD.

The Board has determined that the veteran's service-connected disabilities necessitate regular aid and attendance, qualifying him for special monthly compensation on account of need for aid and attendance. However, he does not meet the criteria for permanent housebound status.

The veteran's claim for service connection for chronic persistent peripheral neuropathy, including as a result of exposure to herbicides, is being remanded for further development.

The veteran's claims for increased evaluations for various service-connected disabilities are being remanded to the RO for additional development.

The VA denied the veteran's claim for an increased disability rating for diabetes mellitus, finding that his condition did not require a restriction in physical activities due to diabetes.

The VA determined that the veteran's right lateral femoral cutaneous neuropathy was not incurred in active military service and therefore denied his claim.

The Board has remanded the case for a personal hearing and to determine if new evidence has been submitted to reopen the claim for service connection of peripheral neuropathy.

The Board found no relationship between the veteran's peripheral neuropathy and his military service, thus denying his claim for service connection.

The Board has denied the veteran's claims for service connection for a sinus disorder, lumbosacral strain with neurological manifestations affecting the left leg, chloracne, and peripheral neuropathy of the hands and feet. The evidence submitted did not change the outcome of these decisions.